The latest price target for Gentex (NASDAQ:GNTX) was reported by JP Morgan on May 14, 2026. The analyst firm set a price target for $28.00 expecting GNTX to rise to within 12 months (a possible 7.78% upside). 14 analyst firms have reported ratings in the last year.

The latest analyst rating for Gentex (NASDAQ:GNTX) was provided by JP Morgan, and Gentex maintained their neutral rating.

The last upgrade for Gentex Corp happened on July 6, 2023 when B of A Securities raised their price target to $33. B of A Securities previously had an underperform for Gentex Corp.

The last downgrade for Gentex Corp happened on April 15, 2025 when Baird changed their price target from $31 to $25 for Gentex Corp.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Gentex, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Gentex was filed on May 14, 2026 so you should expect the next rating to be made available sometime around May 14, 2027.

While ratings are subjective and will change, the latest Gentex (GNTX) rating was a maintained with a price target of $27.00 to $28.00. The current price Gentex (GNTX) is trading at is $25.98, which is out of the analyst’s predicted range.